From the CD20 is a B cell integral membrane protein
capable of initiating growth-modulating signals in human B lymphocytes
upon its engagement with monoclonal anti-CD20 antibodies. In this
report, we demonstrate that treatment of B cells with CD20 antibodies induces rapid redistribution of CD20 into a detergent-insoluble membrane compartment. Redistribution is detected as early as 15 s,
following antibody addition, and involves up to 95% of CD20 molecules,
depending on the antibody used. All of the detergent-insoluble CD20 was
found in the low density fractions of sucrose density gradients,
indicating that CD20 redistributes to glycolipid-rich membrane domains,
analogous to caveolae in some cell types. As CD20 has previously been
shown to associate with Src family tyrosine kinases, their co-existence
in these compartments suggests a link to the role of CD20 in signal
transduction. This study provides insight into the mechanism by which
CD20 commmunicates signals to the cell interior and indicates that the
search for membrane-proximal intracellular signaling partners should be
directed to the Triton-insoluble fraction.
The plasma membrane provides both a barrier and an interface to
the extracellular microenvironment and supports many cell surface
proteins responsible for transmitting extracellular signals to the cell
interior. Increasing evidence supports the notion that, for some
receptors, signal integration involves the nonrandom distribution of
signaling proteins into subcompartments in the plasma membrane (1, 2).
Local variation in lipid content provides one mechanism for the
organization of microdomains in the plasma membrane and permits their
biochemical isolation on the basis of detergent insolubility and
buoyancy on sucrose density gradients (3). In lymphocytes, it has been
established that glycosylphosphatidylinositol
(GPI)-linked1 proteins and
Src family kinases are enriched in these detergent-insoluble microdomains (4, 5), but few integral membrane proteins have been
localized to these areas (6).
CD20 is a 33-35-kDa nonglycosylated integral membrane protein
expressed on all B lymphocytes from the late pre-B cell stage until it
is lost just prior to terminal differentiation into plasma cells. The
cDNA sequence of CD20 predicts that it spans the plasma membrane
four times, with an intracellular location for both amino and carboxyl
tails and a short extracellular loop between the third and fourth
transmembrane domains (7-9). Monoclonal antibodies (mAb) directed against extracellular
epitopes of CD20 can modulate B cell growth and differentiation,
indicating the ability of CD20 to transduce extracellular signals
(10-15). A signaling role for CD20 is further supported by the
activation of tyrosine kinase activity in B cells after their exposure
to CD20 mAbs (16). In addition, evidence suggests that CD20 may also be
involved in the control of intracellular free calcium concentration by regulating both calcium influx (17-19) and mobilization of calcium from intracellular stores (16).
CD20 is tightly associated with Src family kinases and with an
unidentified tyrosine-phosphorylated protein of 75-80 kDa (p75/80) (20). However, the mechanism underlying the ability of CD20 to transmit
signals regulating B cell activation has not been further elucidated.
To explore the molecular basis for differing effects of CD20 mAbs on B
cell activation, the ability of three of these antibodies to
co-precipitate CD20, kinase activity, and tyrosine-phosphorylated
proteins was compared. The results of this study uncovered the
remarkable ability of CD20 to redistribute to a Triton-insoluble, low
density membrane compartment upon binding to anti-CD20 mAb. In many
cell types, this compartment has been equated with caveolae, defined
morphologically as microinvaginations in the plasma membrane, and more
recently, by the presence of caveolin, a resident caveolar protein
(21). In lymphocytes, the apparent absence of both caveolin and
morphologically defined caveolae leaves their designation provisional
in this cell type (22). However, biochemically similar structures,
sometimes referred to as "rafts" or DIGS (detergent-insoluble
glycolipid-enriched structures) (4, 5), have been isolated from
lymphocytes, and we propose that active relocalization of CD20 to these
microdomains is a necessary event in the initiation of CD20 signaling.
In support of this, an activating anti-CD20 mAb was found to uniquely
induce the appearance in the same compartment of a
tyrosine-phosphorylated protein of ~50 kDa.
Cells and Reagents--
Raji B cells were maintained by culture
in RPMI 1640 medium, 5% fetal bovine serum. The CD20-specific mAbs,
2H7 and 1F5, were provided by Dr. J. Ledbetter (Bristol-Myers Squibb,
Seattle, WA). The CD20 mAb B1 was purchased from Coulter Corp.
(Hialeah, FL). Rabbit antiserum to CD20 was generated using a peptide
corresponding to amino acids 25-41 of human CD20 conjugated to
ovalbumin. Anti-phosphotyrosine mAb 4G10 was from Upstate Biotechnology
Inc.
Cell Stimulation and Sample Preparation--
Raji cells were
warmed to 37 °C before incubation with 2H7, 1F5, B1 or
isotype-matched control mAbs (1 µg/106 cells) and then
pelleted and lysed in ice-cold 0.5% Triton X-100 (Pierce) containing
20 mM Tris, pH 7.5, 1 µg/ml leupeptin, 1 µg/ml aprotinin, 1 mM phenylmethylsulfonyl fluoride, and 5 mM EDTA. In time course experiments requiring very short
exposure to antibody, cells were not pelleted but were lysed in 2 × (1%) Triton X-100 detergent buffer. After 15 min on ice, lysates
were centrifuged at 14,000 × g for 15 min at 4 °C
to separate out the insoluble material. The insoluble pellets were
washed 4 times in lysis buffer before addition of 2 × SDS sample
buffer and then subjected to 2 cycles of heating to 100 °C for 5 min, vortexing, and freezing. For immunoprecipitation, post-nuclear
lysates were transferred to clean tubes and mixed with 25 µl of
protein A-Sepharose (Repligen Corp., Cambridge, MA) for 2 h. For
in vitro phosphorylation, immune complexes precipitated from
cell lysates with protein A-Sepharose beads were washed three times in
lysis buffer, twice in kinase buffer (20 mM Pipes, pH 7.2, 10 mM MnCl2, and 5 mM
MgCl2), and resuspended in 25 µl of kinase buffer
containing 5 µCi of [ Immunoblotting--
Membranes were blocked in 5% bovine serum
albumin, incubated with 1/2000 dilution of CD20 antiserum or 4G10 mAb,
and washed, and then bound antibody was detected using protein
A-horseradish peroxidase (Bio-Rad) or anti-mouse IgG-horseradish
peroxidase (Southern Biotechnology Associates, Inc., Birmingham, AL)
and developed by chemiluminescence (Pierce). Pre-stained molecular weight markers (Bio-Rad or NEB) were run on each gel. Bands were visualized using Kodak X-OMAT film (Eastman Kodak Co.)
Immunofluorescence--
Cells (2 × 105) were
suspended and incubated in 100 µl of RPMI 1640 medium, 10% fetal
bovine serum for 15 min at 37 °C with 2H7, 1F5, B1, or
isotype-matched control mAb, washed once, and resuspended for 15 min
with 100 µl of 1/100 dilution of goat anti-mouse IgG conjugated to
fluorescein isothiocyanate (Southern Biotechnology Associates, Inc.).
Experiments as represented in Fig. 5 were performed with modifications
to incubation times as described in the figure legend. After washing,
cells were resuspended in phosphate-buffered saline/0.01% azide and
analyzed on a FACScan cytometer (Becton Dickinson).
Sucrose Density Gradient Analysis--
Raji cells (1 × 107 per gradient) were lysed in 1% Triton X-100 in
MES-buffered saline (MBS; 25 mM MES, pH 6.5, 150 mM NaCl, 1 µg/ml leupeptin, 1 µg/ml aprotinin, 1 mM phenylmethylsulfonyl fluoride), mixed with sucrose to a
final concentration of 40%, overlayered with a 5-30% sucrose density
gradient as described (3, 23), and then centrifuged at 37,000 rpm for
16 h. Fractions corresponding to 12-20% sucrose on the gradient
were collected, diluted in MBS such that the final concentration of
sucrose was less than 5%, and pelleted by centrifugation at 37,000 rpm
for 1 h, and the Triton X-100 insoluble pellets were then
solublized in SDS sample buffer.
Co-precipitation of p75/80 by Different CD20 mAb Is Inversely
Proportional to the Amount of CD20 Precipitated--
Binding of
anti-CD20 mAb to B cells has been shown to induce tyrosine kinase
activation, tyrosine phosphorylation of phospholipase C Immunology Research Group,
ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References
INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References
EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References
-32P]ATP (specific activity,
3000 Ci/mmol, Amersham Corp.). Reactions were allowed to proceed at
room temperature for 15 min and then were stopped by the addition of 3 µl of 0.5 M EDTA. Samples were washed with lysis buffer,
heated to 100 °C for 5 min in 2 × SDS sample buffer, run on
10% polyacrylamide gels, and transferred to Immobilon P (Millipore).
Bands were visualized by autoradiography using Kodak X-OMAT film.
RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References
, and
mobilization of intracellular calcium (16). Further, CD20 mAbs
co-precipitate Src family kinases and an unidentified 75-80-kDa
phosphoprotein (20), suggesting a mechanism for signal transduction
through CD20-associated tyrosine kinase activation. There appear to be
at least two distinct epitopes in the small extracellular loop of CD20,
one recognized by the antibody 1F5 and another, possibly overlapping
epitope, recognized by other CD20 mAbs (24). The 1F5 antibody is unique
in its ability to induce c-myc transcription and entry of
resting B cells into the G1 phase of the cell cycle,
whereas all CD20 mAb, including 1F5, inhibit mitogen-induced antibody
production by activated B cells (10-15). To explore the molecular
basis for the unique activating property of the 1F5 anti-CD20 mAb, its
ability to co-precipitate kinase activity and tyrosine-phosphorylated
proteins was compared with two other CD20 mAbs, 2H7 and B1. Indirect
surface immunofluorescence staining demonstrated that all three of
these antibodies bind well to Raji cells (Fig.
1). However, there were marked
differences in their ability to co-precipitate p75/80 and kinase
activity. CD20 complexes precipitated by mAb 2H7 contained more p75/80, as detected by anti-phosphotyrosine, and more kinase activity, as
measured by in vitro phosphorylation, than CD20 complexes
precipitated by either 1F5 or B1 (Fig.
2). The increased amounts of
CD20-associated proteins precipitated by 2H7 might have been partially
accounted for by the slightly higher level of binding of 2H7 to the
cells (Fig. 1). However, the amount of CD20 precipitated by the 3 mAb was estimated by blotting the same membranes with a CD20 antiserum, and
surprisingly, there was significantly less CD20 precipitated by 2H7
than by either 1F5 or B1 (Fig. 2).
View larger version (18K):
[in a new window]
Fig. 1.
FACScan profiles of CD20 mAb binding to Raji
cells. Indirect immunofluorescence was performed as described
under "Experimental Procedures." Solid profile
represents the binding of the fluorescein isothiocyanate-labeled
secondary antibody. Open profiles show binding of the
primary antibodies 1F5, 2H7, and B1 as indicated.
View larger version (56K):
[in a new window]
Fig. 2.
Inverse correlation among CD20 mAbs between
precipitation of CD20 and co-precipitation of associated proteins.
Raji B cells (107) were incubated with control mAb
(CT) or CD20 mAb (1F5, 2H7, B1) for 15 min before lysis.
CD20 and associated proteins were precipitated by addition of protein
A-Sepharose. Associated proteins were detected by anti-phosphotyrosine
blot (upper left) or in vitro kinase assay
(upper right). The same membranes were then probed for CD20
(bottom). Note that CD20 migrates as a 33/35-kDa doublet due
to differential serine/threonine phosphorylation (41, 42). The lower
band is predominant and, at limiting amounts, is the only one
detected.
CD20 Becomes Triton-insoluble after Antibody Binding-- The reduced amount of CD20 precipitated by 2H7 mAb was at odds with both the high level of surface staining (Fig. 1) and the higher amounts of CD20-co-precipitated proteins relative to 1F5 and B1 (Fig. 2). These data suggested to us that CD20 may have changed its solubility properties following 2H7 mAb binding, resulting in translocation of CD20 from the Triton-soluble fraction to an insoluble fraction. To test this, Triton-soluble lysates prepared from cells treated with either control or CD20 mAbs were tested for the presence of CD20 by immunoblotting. A significant reduction in the amount of CD20 was detected in lysates prepared from cells pretreated with 2H7 mAbs (Fig. 3, upper panel). The proportion of CD20 that was translocated was estimated to be 80-95% when the cells were exposed to 2H7 for 15 min. In the same time frame, approximately 40-60% and 5-10% of CD20 was lost following exposure to 1F5 and B1 mAbs, respectively. The Triton-insoluble material obtained after centrifugation of the lysates was solubilized in SDS sample buffer and similarly analyzed for the presence of CD20 (Fig. 3, lower panel). When Raji cells were lysed without prior incubation with CD20 mAb, there was no CD20 detectable in the Triton-insoluble fraction. However, addition of either 1F5 or 2H7 CD20 antibody to the cells 15 min prior to lysis resulted in translocation of a significant fraction of CD20 to the insoluble compartment. A much smaller amount of CD20 was translocated in response to B1. The amount of insoluble CD20 varied with the antibody used, in inverse proportion to the amount of soluble CD20 precipitated by the same antibodies. Thus, the 2H7 antibody, which precipitated less soluble CD20 (Fig. 2), was the most effective in inducing CD20 to become insoluble. In contrast, the B1 mAb precipitated the most CD20 from the soluble fraction and was least effective at inducing CD20 insolubility.
|
|
|
Buoyancy of Triton-insoluble CD20 on Sucrose Density Gradients-- Insolubility of non-nuclear proteins in Triton X-100 has been attributed to either cytoskeletal attachment or to localization to lipid-rich membrane compartments. To distinguish between these two possibilities, cell lysates were analyzed by centrifugation on sucrose density gradients. Both the insoluble pellet, in which cytoskeletal proteins are found, and the insoluble buoyant fractions pooled from 12-20% sucrose were tested for the presence of CD20 (Fig. 6). All of the insoluble CD20 material was detected in the 12-20% region of the gradient, consistent with localization to a lipid-rich membrane compartment (3, 25).
|
Tyrosine-phosphorylated ~50-kDa Protein Detected Uniquely in the Insoluble Fraction of 1F5-treated Cells-- Since CD20 is associated with Src family tyrosine kinases, primarily Lyn, and with a tyrosine-phosphorylated protein, p75/80, the Triton-insoluble membrane fraction in which CD20 was detected was probed by Western blot using anti-lyn and anti-phosphotyrosine. Lyn is one of several Src family kinases enriched in Triton-insoluble membrane compartments (6),2 and no change in the abundance of Lyn in this compartment was detected upon CD20 translocation (data not shown). Three major bands of approximately 75, 60, and 55 kDa were detected by anti-phosphotyrosine blot in all samples at similar intensity (Fig. 7). The identity of these proteins is not known, but bands in the 55-60-kDa region are likely to include Src family kinases. Of particular interest is that an additional phosphoprotein, migrating at approximately 50 kDa, was uniquely and reproducibly observed in samples pretreated with the activating 1F5 mAb, but not with either 2H7 or B1 (Fig. 7).
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
This report describes the active relocalization of the cell surface protein CD20 into a low density detergent-insoluble membrane compartment upon exposure of Raji B cells to CD20 mAb. Despite the relatively hydrophobic nature of CD20, it is not intrinsically resistant to detergent lysis. All detectable CD20 is found in the Triton-soluble fraction of unstimulated cells and is only induced to become insoluble by the addition to viable cells of mAb against extracellular CD20 epitopes. This phenomenon is not unique to Raji cells since it was observed in several unrelated B cell lines as well as in freshly isolated tonsillar B cells (data not shown). The reason for differences in the degree of insolubility induced by various CD20 mAbs is unclear at present. It is not likely to be due simply to differences in the numbers of CD20 molecules engaged since the B1 mAb binds to CD20 at least as well as 1F5 (Fig. 1), and yet approximately 5-fold more CD20 protein is redistributed by 1F5. It is possible that differences in either affinity or fine specificity account for the observed effects. Antibody binding to CD20 may induce a conformational and/or post-translational modification that causes the molecule to translocate to an insoluble compartment or to become insoluble in situ, perhaps by oligomerization. Alternatively, CD20 may be associated with, or be induced to associate with, a GPI-linked protein or other molecule with a predisposition toward localization to the insoluble fraction. GPI-linked proteins are enriched in detergent-insoluble low density compartments (6, 26, 27) thought to represent in vitro isolates of caveolae (3). Under electron microscopy, low density detergent-insoluble fractions can be seen to contain vesicles similar to those formed by caveolae following membrane disruption in Triton X-100 (6, 22, 23) and are enriched in many of the same proteins found in caveolae (see below). Nevertheless, resolution of the issue of whether there are distinct non-caveolar detergent-insoluble microdomains awaits the characterization of additional components in these compartments.
Data is accumulating to implicate these membrane microdomains in the integration of extracellular signals within the plasma membrane (1, 2). In addition to being enriched in cholesterol, sphingomyelin, glycosphingolipids, and GPI-linked proteins, they contain a variety of proteins involved in signal transduction, including Src family tyrosine kinases, G-protein-coupled receptors, calcium channels, and ATPases (28, 29). Caveolae may in fact be major sites for calcium entry/efflux (30, 31), and in this context, it is interesting to note that CD20 appears to be capable of forming calcium channels (17-19).
Further evidence for a role of caveolae or analogous membrane
microdomains in signal transduction stems from recent observations that
growth factor receptors reside and initiate signaling in these
compartments (32-34). However, there are only a few reports describing
redistribution of cell surface signaling molecules into these domains.
For example, the muscarinic acetylcholine receptor is reversibly
translocated into caveolae in response to agonists (35). GPI-linked
proteins, which have also been implicated in signaling, become enriched
in caveolae upon antibody cross-linking (36, 37). In addition, the high
affinity receptor for IgE (FcRI), when aggregated,
redistributes to detergent-resistant membrane domains (38,
39).
CD20 shares significant sequence homology with the subunit of the
Fc
RI complex, particularly in regions corresponding to the putative
membrane domains (40). In contrast to activated CD20, which remains
insoluble in 1% Triton X-100 (Fig. 5), localization of Fc
RI to
membrane domains is extremely sensitive to detergent concentration and
is released from the domains in concentrations of Triton X-100 greater
than 0.05% (39). Thus, the specific membrane compartment, and/or the
mechanisms underlying CD20 and Fc
RI translocation are likely to be
different. Furthermore, detergent-insoluble CD20 clearly remains
membrane-associated, as assessed by FACScan analysis (Fig.
5B), and by confocal microscopy3 whereas the
Fc
RI complex becomes internalized (39).
To our knowledge, this is the first description of a lymphocyte cell surface molecule that appears to be completely excluded from detergent-insoluble domains in unstimulated cells but can be induced to translocate to that compartment. The molecular composition of the compartment to which CD20 translocates is presently unknown, but a focus on its components may allow us to identify key downstream elements for CD20-mediated signaling and function. The physiological relevance of CD20 redistribution is suggested by the selective alteration in the profile of tyrosine-phosphorylated substrates in the corresponding compartment induced by the activating mAb 1F5 even though the extent of CD20 redistribution induced by 1F5 is lower than that of 2H7. The activating properties of the 1F5 mAb are thus, for the first time, correlated with an early intracellular signaling event, indicating that the Triton-insoluble membrane fraction is the relevant signaling compartment to investigate to characterize CD20-initiated signal transduction pathway. The ~50-kDa protein may be constitutively resident in the insoluble compartment, becoming tyrosine phosphorylated in response to 1F5 ligation, or it may itself become translocated with CD20. We anticipate that the signal transduction pathways initiated by 1F5 engagement, leading to cell cycle progression, will now become amenable to analysis. CD20 co-precipitates with the Src family kinase Lyn (20), a resident protein in the Triton-insoluble fraction in lymphocytes (6).3 The amount of Lyn in the corresponding fractions did not change upon CD20 translocation (data not shown), however, we have not assessed whether its specific activity is altered.
A physiological stimulus for CD20 redistribution has not yet been identified. Given the profound effect of antibodies against the extracellular region of CD20 on the state of B cell activation, we speculate that either a putative CD20 ligand or an interacting protein may mediate redistribution and that the consequences of CD20 redistribution will relate to its roles in signal transduction and/or calcium control.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank Dr. J. Ledbetter for the 2H7 and 1F5 mAbs and Dr. B. Winston, Dr. M. Hollenberg, and I. Popoff for comments on the manuscript.
![]() |
FOOTNOTES |
---|
* This work was supported by a grant from the Canadian Cancer Society with funds from the Terry Fox Run and by scholarship awards from the Alberta Heritage Foundation for Medical Research (to S. R. and J. D.) and the Medical Research Council of Canada (to J. D.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed: Dept. of Medical Biochemistry, The University of Calgary, Health Sciences Center, 3330 Hospital Dr. NW, Calgary, Alberta T2N 4N1, Canada. Tel.: 403-220-4566; Fax: 403-283-1267; E-mail: jdeans{at}acs.ucalgary.ca.
1 The abbreviations used are: GPI, glycosylphosphatidylinositol; mAb, monoclonal antibody; MES, 4-morpholineethanesulfonic acid.
2 S. Robbins, N. Quintrell, and J. M. Bishop, unpublished observations.
3 P. van den Elzen and J. Deans, unpublished observations.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|